Citations 1
Zoledronic acid (ZA) effectively inhibits cancer treatment-induced bone loss (CTIBL) in postmenopausal women (PMW) with early breast cancer (BCa) receiving adjuvant letrozole (Let): 12 mos BMD results of the Z-FAST trial
Brufsky, Adam , Harker, W G, Carroll, Robert R., Tan-Chiu, Elizabeth, Seidler, C. W., Lacerna, Leo V., Thomas, E. W. Prosser, Perez, Edith A. , Beck, J. Thaddeus , Thomas, E., Brufsky, Adam M
Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 533-533
